1.0 semaglutide Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer's Trial Another Weight-Loss Trial Win for

Its primarily approved for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition, like diabetes, high blood pressure or a risk of cardiovascular events

While these drugs offer important treatments for obesity and diabetes, conditions that disproportionately impact Black Americans and underserved populations, their potential is undermined by systemic barriers that prioritize profits over public health

The first three parts (Part A, B, C) are completed (130, 132)

February 5, 2023

Hong Cai: data collection and analysis, and help to draft the manuscript

: ,